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Fifteen years after the initial detection of Rickettsia slo-
vaca in ticks in Portugal, 3 autochthonous cases of R. slo-
vaca infection were diagnosed in humans. All patients had 
an eschar on the scalp and lymphadenopathy; 2 patients 
had facial edema. R. slovaca infection was confirmed by 
serologic testing, culture, and PCR.
Rickettsia slovaca is a pathogenic, tick-borne, spotted fever group (SFG) rickettsiae that was initially isolated 
in 1968 from a Dermacentor marginatus tick in Slovakia. 
R. slovaca infection has been described in humans from 
several countries (1,2), but a laboratory-confirmed case of 
R. slovaca infection was first reported in a patient in France 
in 1997 (3). R. slovaca has since been reported in humans 
in France, Spain, Hungary, Slovakia, Bulgaria, Italy, and 
Germany (4–7). 
The analysis of a large series of patients reporting the 
common clinical signs of enlarged regional lymph nodes 
associated with the tick bite led to the names that have 
been used to designate this rickettsial disease, tick-borne 
lymphadenopathy (TIBOLA) and Dermacentor-borne-ne-
crosis-erythema lymphadenopathy (8,9). Apart from Medi-
terranean spotted fever, TIBOLA may be among the most 
prevalent tick-borne rickettsioses in Europe (4). 
In Portugal, R. slovaca was initially described in 1995 
in D. marginatus ticks and later in D. reticulatus ticks 
(10,11) but has not been identified in humans. We report 
3 laboratory-confirmed cases of R. slovaca infection in hu-
man patients in Portugal. 
The Study
During October 2010–May 2012, three Caucasian 
women who sought care at the emergency department of 
University Hospitals of Coimbra (HUC), Coimbra, Portu-
gal, were admitted with clinical signs and symptoms com-
patible with a rickettsiosis. The patients were residents of 
rural areas of the Coimbra district, and all were at risk for 
tick exposure through fieldwork or direct contact with do-
mestic animals (Table). Two patients reported that they had 
removed a tick from the scalp. 
Physical examination showed a single inoculation es-
char surrounded by an erythematous halo on the scalps 
of all 3 patients; 1 patient later had alopecia develop at 
the tick bite site (Table; Figure 1). Two patients also had 
painful cervical and occipital lymphoadenopathies, ac-
companied by unilateral or bilateral peri-orbital edema 
(Table; Figure 2). Fever (37.8°C) and a maculopapular 
rash in the trunk and upper limbs were each visible and 
reported in 1 patient. 
Laboratory testing showed a slight increase of C-
reactive protein in 2 patients and a mild thrombocytope-
nia in 1, but other results were within normal limits. The 
patients were treated with doxycycline (200 mg/d) for 7 
days with progressive resolution of the clinical signs (e.g., 
edema, rash).
To confirm the diagnosis of R. slovaca infection, se-
rum samples and skin biopsy specimens collected at dif-
ferent times of infection from all patients (Table) were 
sent to the Portuguese reference laboratory for rickettsio-
ses. Serologic response was analyzed by in-house immu-
nofluorescence assay using R. slovaca PoTi443 strain as 
antigen, as described (12). Seroconversion in 2 consecu-
tive samples was demonstrated in patients 1 and 2 by the 
appearance or increasing levels of IgM and IgG against 
rickettsiae (Table). Patient 3 had only 1 acute serum sam-
ple; test results showed titers for IgM were 32 and for 
IgG were 64. 
Molecular detection of rickettsial DNA on eschar bi-
opsies was performed by PCR, as described (13). Briefly, 
DNA was extracted from each skin biopsy sample by us-
ing a DNeasy Tissue Kit (QIAGEN, Hilden, Germany), 
according to the manufacturer’s instructions. Nested PCR 
amplification targeting ompA (190-kDa protein) and ci-
trate synthase (gltA) fragment genes of Rickettsia spp. 
and sequencing of positive products were done as de-
scribed (13). The sequences were edited by using Laser-
gene software (DNASTAR, Madison, WI, USA). BLAST 
analysis (http://blast.ncbi.nlm.nih.gov) showed 100% ho-
mology with gltA (382/382 bp) and ompA (323/323 bp) 
of R. slovaca isolate PoTi443 (GenBank accession nos. 
HM149281 and HM149286), which was detected in D. 
marginatus ticks in Portugal (11).
Skin samples from patients 1 and 3 were used for rick-
ettsial isolation attempts by using Vero E6 cell line and 
shell-vial technique as described (14). (The sample from 
patient 2 was too small to use for both tests.) After 8 days’ 
incubation at 32°C, growth of Rickettsia spp. was detected 
and visualized by Gimenez staining and imunofluores-
cence assay. Positive culture was confirmed for patient 1; 
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however, the culture from patient 3 was contaminated. The 
Rickettsia spp. isolate was characterized by PCR and se-
quencing as described above for molecular detection. This 
analysis provided definitive confirmation of the isolate as 
R. slovaca.
Conclusions
We report 3 confirmed cases of TIBOLA in Portuguese 
patients, an indication of the emergence of this rickettsial 
disease in Portugal. The patients were all women, which is 
in accordance with previous findings of a higher risk for in-
fection for women and children (4). Our patients also each 
showed a tick bite on the scalp associated with the enlarge-
ment of lymph nodes, as described in other clinical reports 
(3,4–7,9,15). 
Two (67%) of the patients we describe showed fa-
cial edema, which is notably higher than Parola et al. 
reported in his series of patients, where facial edema oc-
curred in 6 (19%) of 49 patients (15). Although our num-
ber of patients was very small, this sign, associated with 
the eschar on the scalps of patients 1 and 2, is what led 
clinicians to further investigate which species of Rickett-
sia was involved in these infections. One of the patients 
showed residual alopecia, but no patients reported persis-
tent fatigue; these have been described in other patients 
as frequent complaints in the convalescent stage of dis-
ease (3,5). Low-grade fever (37.8°C) and maculopapular 
rash each occurred in 1 patient, similar to rates in previous 
reports for fever (12%–67%) and rash (14%–23%) (3,4,15).
Aside from the typical manifestations of TIBOLA in 
these patients, isolation and PCR detection followed by 
genetic characterization of isolates were essential to con-
firm R. slovaca infection. Although the patients showed 
detectable antibodies against R. slovaca, diagnosis on the 
basis of serologic results only does not distinguish among 
various SFG rickettsiae, and in Portugal, different Rickett-
sia spp. can circulate during the same time of year (13,14). 
The onset of symptoms (media incubation time 5.5 days) 
in these patients was in October, April, and May, timing 
that is associated with seasonal activity of Dermacentor 
spp. ticks. Prevalence rates of R. slovaca in these ticks in 
Europe range from 21% in Hungary to 40.6% in Spain and 
 
Table. Epidemiologic, clinical and microbiologic characteristics of 3 patients infected with Rickettsia slovaca, Portugal 
Characteristic Patient 1 Patient 2 Patient 3 
Epidemiologic    
 Age, y/sex 50/F 53/F 30/F 
 Date of illness onset 2010 Oct 2012 Apr 2012 May 
 Type of residence  Rural Rural Rural 
 At-risk activity Field worker Field worker, contact with 
domestic animals 
Contact with dogs 
 Reported tick bite Yes Yes NA 
Clinical characteristics    
 Incubation time, d*† 4 7 NA 
 Fever Yes, 37.8°C No No 
 Eschar on scalp Yes Yes Yes 
 Rash No Yes, maculopapular No 
 Painful cervical/occipital lymphadenopathy Yes No Yes 
 Facial edema Yes Yes No 
 Headache Yes No No 
 Localized alopecia No Yes No 
Laboratory diagnostics    
 Antibodies against R. slovaca by IFA‡    
  Sample 1, titer IgM/IgG Negative 32/64 32/64 
  Sample 2, titer IgM/IgG 32/128 1,024/1,024 ND 
 Culture from eschar Positive ND Contaminated 
 PCR from eschar Positive Positive Positive 
*All patients were treated with doxycycline. NA, not available; ND, not done; IFA, immunofluorescence assay. 
†From tick bite to symptom onset. 
‡Positive cutoff values, IgM = 32; IgG = 128. 
 
Figure 1. Inoculation eschar surrounded by an erythematous halo 
at the site of a tick bite on the scalp of a female patient in Portugal. 
Tick-borne lymphoadenopathy caused by Rickettsia slovaca 
infection was later confirmed.
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41.5% in Portugal (11). Based on the similar prevalence 
of R. slovaca in ticks in Portugal and Spain, and in com-
parison with the large number of patients in Spain with R. 
slovaca infection, it is possible that cases of R. slovaca in-
fection in Portugal are not being recognized by clinicians 
or are being misdiagnosed as Mediterranean spotted fever. 
Although R. slovaca is the main etiologic agent as-
sociated with TIBOLA, recent studies have indicated that 
patients with the same characteristic clinical signs may be 
infected with other Rickettsia species, such as R. rioja or R. 
raoultii (4,11), which are also transmitted by Dermacen-
tor spp. ticks. Oteo et al. reported that, in Spain, R. rioja 
was the causative agent for almost half of patients with TI-
BOLA (4). In Portugal, a high prevalence (58.5%) of R. 
raoultii has found in Dermacentor spp., but this rickettsial 
species has not been detected in humans (11). Because clin-
ical signs can overlap in different rickettsial infections and 
serologic testing cannot distinguish among SFG rickettsiae, 
molecular characterization is essential to clarifying the epi-
demiology of these rickettsial infections.
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Figure 2. Left peri-orbital edema in a female patient in Portugal. 
Tick-borne lymphoadenopathy caused by Rickettsia slovaca 
infection was later confirmed.
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